Journal list Promote Sponsor
verified SJR 2,091 · Q1 • database Scopus / SJR & Web of Science indexed
Reviews in Medical Virology
United Kingdom · John Wiley and Sons Ltd
workspace_premium Q1 — Infectious Diseases lock_open Open Access

Reviews in Medical Virology

Reviews in Medical Virology is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 110. It has a price of 3083 €. It has an SJR impact factor of 2,091 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,091.

ISSN: 1052-9276
Publisher: John Wiley and Sons Ltd
Category: Infectious Diseases
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,091 Q1
H-index 110
Acceptance rate pie_chart
25% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.083 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,091

H-index

110

Docs (year)

107

Docs 3y

315

Total refs

11209

Cites 3y

2398

Citable 3y

289

Cites/Doc 2y

7.6

Ref/Doc

104.76

Immediate OA

3083 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Diagnosis of congenital CMV infection via dried blood spots

View more

When prevalence of infection may not directly reflect the burden of disease

View more

Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)

View more

Hantavirus infections in Europe and their impact on public health

View more

Generation of influenza A virus from cloned cDNAs ? historical perspective and outlook for the new millenium

View more

Functional association between viral and cellular transcription during influenza virus infection

View more

From restriction factors to restriction enzymes

View more

Facilitating viral recombination

View more

Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome

View more

Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer

View more

Ebola in West Africa: the end of the first year

View more

Drug abuse, innate immunity and hepatitis C virus

View more
SHOW MORE ARTICLES

Does SV40 infection contribute to the development of human cancers?

View more

Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?

View more

Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace

View more

Definitions for warning signs and signs of severe dengue according to the WHO 2009 classification: Systematic review of literature

View more

Defining the boundaries of public health

View more

Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C

View more

Classic paper: Fenner on the exanthemata

View more

Boom and bust from influenza

View more

Antiviral developments

View more

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8

View more

Annexin A2 extracellular translocation and virus interaction: A potential target for antivirus-drug discovery

View more

An earlier role for viral pharmacodynamics

View more

FAQs